Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigation of type I interferon responses in ANCA-associated vasculitis

15 Apr 2021

Abstract excerpt

Type I interferon (IFN) dysregulation is a major contributory factor in the development of several autoimmune diseases, termed type I interferonopathies, and is thought to be the pathogenic link with chronic inflammation in these conditions. Anti-neutrophil cytoplasmic antibody (ANCA)-Associated Vasculitis (AAV) is an autoimmune disease characterised by necrotising inflammation of small blood vessels. The...

Topics

Join the communities discussing this publication.

Cell Adhesion Molecules Research
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Vasculitis and related conditions

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33859290
DOI: 10.1038/s41598-021-87760-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigation of type I interferon responses in ANCA-associated vasculitisPMID 33859290Read ↗

A stronger type I interferon signature distinguishes ANCA-associated vasculitis phenotypes and predicts kidney prognosis.Semantic proximity Read ↗

Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases.Semantic proximity Read ↗

The Role of Type 1 Interferon in Systemic SclerosisSemantic proximity Read ↗

Optimal Selection of IFN-α-Inducible Genes to Determine Type I Interferon Signature Improves the Diagnosis of Systemic Lupus ErythematosusSemantic proximity Read ↗

Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analysesSemantic proximity Read ↗

Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host DiseaseSemantic proximity Read ↗

The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosusSemantic proximity Read ↗

Type I interferon dysregulation drives distinct pathogenic pathways in early- and late-onset lupus nephritisSemantic proximity Read ↗

Neutrophil single-cell analysis identifies a uniquely primed subset and provides insights into predicting relapse of autoimmune small vessel vasculitisSemantic proximity Read ↗

Targeting of type I interferon in systemic autoimmune diseases.Semantic proximity Read ↗

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?Semantic proximity Read ↗

Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.